11 employees
Avivo Biomedical operates as a preclinical-stage company.
2020
$250K
from 2 investors over 2 rounds
ABOzymes Biomedical Inc. raised $250K on March 31, 2022
Investors: Genome British Columbia
ABOzymes Biomedical Inc. raised undisclosed on July 15, 2020
Investors: entrepreneurship@UBC